These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31290881)

  • 1. Rhodium(iii) complexes with isoquinoline derivatives as potential anticancer agents: in vitro and in vivo activity studies.
    Khan TM; Gul NS; Lu X; Kumar R; Choudhary MI; Liang H; Chen ZF
    Dalton Trans; 2019 Aug; 48(30):11469-11479. PubMed ID: 31290881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
    Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhodium (II) complex with 2-benzoylpyridine, a novel potential chemotherapeutic drug, induces cell cycle arrest and apoptosis in HepG2 cells.
    Wang X; Li Y; Lin M; Jin J; Huang Z
    Biometals; 2017 Dec; 30(6):903-915. PubMed ID: 28993927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of apoptosis in HepG-2 cells by ruthenium(II) complexes through an intrinsic ROS-mediated mitochondrial dysfunction pathway.
    Zeng CC; Lai SH; Yao JH; Zhang C; Yin H; Li W; Han BJ; Liu YJ
    Eur J Med Chem; 2016 Oct; 122():118-126. PubMed ID: 27344489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxoaporphine Metal Complexes (Co
    Qin JL; Shen WY; Chen ZF; Zhao LF; Qin QP; Yu YC; Liang H
    Sci Rep; 2017 Apr; 7():46056. PubMed ID: 28436418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of substituents on DNA and protein binding of cyclometalated Ir(iii) complexes and anticancer activity.
    Mukhopadhyay S; Singh RS; Paitandi RP; Sharma G; Koch B; Pandey DS
    Dalton Trans; 2017 Jul; 46(26):8572-8585. PubMed ID: 28640302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into anticancer activity and mechanism of action of a ruthenium(II) complex in human esophageal squamous carcinoma EC109 cells.
    Guo L; Lv G; Qiu L; Yang H; Zhang L; Yu H; Zou M; Lin J
    Eur J Pharmacol; 2016 Sep; 786():60-71. PubMed ID: 27262377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands.
    Khan TM; Gul NS; Lu X; Wei JH; Liu YC; Sun H; Liang H; Orvig C; Chen ZF
    Eur J Med Chem; 2019 Feb; 163():333-343. PubMed ID: 30529636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation.
    Peng YB; Tao C; Tan CP; Zhao P
    J Inorg Biochem; 2021 May; 218():111400. PubMed ID: 33684684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
    Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
    BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids.
    Li Y; Gu Z; Zhang C; Li S; Zhang L; Zhou G; Wang S; Zhang J
    Eur J Med Chem; 2018 Jan; 144():662-671. PubMed ID: 29289889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity.
    Lu X; Wu YM; Yang JM; Ma FE; Li LP; Chen S; Zhang Y; Ni QL; Pan YM; Hong X; Peng Y
    Eur J Med Chem; 2018 May; 151():226-236. PubMed ID: 29614419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts.
    Geldmacher Y; Splith K; Kitanovic I; Alborzinia H; Can S; Rubbiani R; Nazif MA; Wefelmeier P; Prokop A; Ott I; Wölfl S; Neundorf I; Sheldrick WS
    J Biol Inorg Chem; 2012 Apr; 17(4):631-46. PubMed ID: 22358334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoquinoline derivatives Zn(II)/Ni(II) complexes: Crystal structures, cytotoxicity, and their action mechanism.
    Huang KB; Mo HY; Chen ZF; Wei JH; Liu YC; Liang H
    Eur J Med Chem; 2015 Jul; 100():68-76. PubMed ID: 26071859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
    Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
    Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms.
    Ye RR; Tan CP; Chen MH; Hao L; Ji LN; Mao ZW
    Chemistry; 2016 Jun; 22(23):7800-9. PubMed ID: 27106876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological study of the effect of water soluble [N-(2-hydroxybenzyl)-L-aspartato] gallium complexes on breast carcinoma and fibrosarcoma cells.
    Mohsen A; Saby C; Collery P; Sabry GM; Hassan RE; Badawi A; Jeannesson P; Desmaële D; Morjani H
    J Biol Inorg Chem; 2016 Oct; 21(7):837-49. PubMed ID: 27484500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.